{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T14:18:12Z","timestamp":1793110692804,"version":"4.5.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2023,5,16]],"date-time":"2023-05-16T00:00:00Z","timestamp":1684195200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,5,16]],"date-time":"2023-05-16T00:00:00Z","timestamp":1684195200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2022A1515011670"],"award-info":[{"award-number":["2022A1515011670"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Key Research and Development Program of Guangzhou City","award":["202206010046"],"award-info":[{"award-number":["202206010046"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1007\/s00259-023-06262-9","type":"journal-article","created":{"date-parts":[[2023,5,16]],"date-time":"2023-05-16T04:02:25Z","timestamp":1684209745000},"page":"3072-3083","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Biodistribution and radiation dosimetry in cancer patients of the ascorbic acid analogue 6-Deoxy-6-[18F] fluoro-L-ascorbic acid PET imaging: first-in-human study"],"prefix":"10.1007","volume":"50","author":[{"given":"Yali","family":"Long","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renbo","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinchong","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangsong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihao","family":"Zha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,16]]},"reference":[{"key":"6262_CR1","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/s41568-019-0135-7","volume":"19","author":"B Ngo","year":"2019","unstructured":"Ngo B, Van Riper JM, Cantley LC, Yun J. Targeting cancer vulnerabilities with high-dose vitamin C. Nat Rev Cancer. 2019;19:271\u201382.","journal-title":"Nat Rev Cancer"},{"key":"6262_CR2","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1186\/s13046-021-02134-y","volume":"40","author":"F B\u00f6ttger","year":"2021","unstructured":"B\u00f6ttger F, Vall\u00e9s-Mart\u00ed A, Cahn L, Jimenez CR. High-dose intravenous vitamin C, a promising multi-targeting agent in the treatment of cancer. J Exp Clin Cancer Res. 2021;40:343.","journal-title":"J Exp Clin Cancer Res"},{"key":"6262_CR3","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.chest.2020.02.049","volume":"158","author":"J Iglesias","year":"2020","unstructured":"Iglesias J, Vassallo AV, Patel VV, Sullivan JB, Cavanaugh J, Elbaga Y. Outcomes of metabolic resuscitation using ascorbic acid, thiamine, and glucocorticoids in the early treatment of sepsis: the ORANGES trial. Chest. 2020;158:164\u201373.","journal-title":"Chest"},{"key":"6262_CR4","doi-asserted-by":"crossref","unstructured":"Marik P.E. Hydrocortisone, ascorbic acid and thiamine (HAT therapy) for the treatment of sepsis. Focus on Ascorbic Acid. Nutrients. 2018;10:1762.","DOI":"10.3390\/nu10111762"},{"key":"6262_CR5","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s10456-020-09719-9","volume":"23","author":"MT Islam","year":"2020","unstructured":"Islam MT. Angiostatic effects of ascorbic acid: current status and future perspectives. Angiogenesis. 2020;23:275\u20137.","journal-title":"Angiogenesis"},{"key":"6262_CR6","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/cr.2016.7","volume":"26","author":"J van der Reest","year":"2016","unstructured":"van der Reest J, Gottlieb E. Anti-cancer effects of vitamin C revisited. Cell Res. 2016;26:269\u201370.","journal-title":"Cell Res"},{"key":"6262_CR7","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1186\/s13046-020-01738-0","volume":"39","author":"W Darwiche","year":"2020","unstructured":"Darwiche W, Gomila C, Ouled-Haddou H, et al. Ascorbic acid (vitamin C) synergistically enhances the therapeutic effect of targeted therapy in chronic lymphocytic leukemia. J Exp Clin Cancer Res. 2020;39:228.","journal-title":"J Exp Clin Cancer Res"},{"key":"6262_CR8","doi-asserted-by":"crossref","unstructured":"Reczek CR, Chandel NS. CANCER. Revisiting vitamin C and cancer. Science. 2015;350:1317-1318.","DOI":"10.1126\/science.aad8671"},{"key":"6262_CR9","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/j.ccell.2018.07.014","volume":"34","author":"N Shenoy","year":"2018","unstructured":"Shenoy N, Creagan E, Witzig T, Levine M. Ascorbic acid in cancer treatment: let the phoenix fly. Cancer Cell. 2018;34:700\u20136.","journal-title":"Cancer Cell"},{"key":"6262_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41698-017-0044-8","volume":"2","author":"H Lv","year":"2018","unstructured":"Lv H, Wang C, Fang T, et al. Vitamin C preferentially kills cancer stem cells in hepatocellular carcinoma via SVCT-2. NPJ Precis Oncol. 2018;2:1.","journal-title":"NPJ Precis Oncol"},{"key":"6262_CR11","doi-asserted-by":"publisher","first-page":"211","DOI":"10.3389\/fphar.2020.00211","volume":"11","author":"FJ Roa","year":"2020","unstructured":"Roa FJ, Pe\u00f1a E, Gatica M, et al. Therapeutic use of vitamin c in cancer: physiological considerations. Front Pharmacol. 2020;11:211.","journal-title":"Front Pharmacol"},{"key":"6262_CR12","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1038\/onc.2012.176","volume":"32","author":"SW Hong","year":"2013","unstructured":"Hong SW, Lee SH, Moon JH, et al. SVCT-2 in breast cancer acts as an indicator for L-ascorbate treatment. Oncogene. 2013;32:1508\u201317.","journal-title":"Oncogene"},{"key":"6262_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.canlet.2017.03.039","volume":"398","author":"C Wang","year":"2017","unstructured":"Wang C, Lv H, Yang W, et al. SVCT-2 determines the sensitivity to ascorbate-induced cell death in cholangiocarcinoma cell lines and patient derived xenografts. Cancer Lett. 2017;398:1\u201311.","journal-title":"Cancer Lett"},{"key":"6262_CR14","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1161\/CIRCULATIONAHA.120.050553","volume":"144","author":"AC Ostriker","year":"2021","unstructured":"Ostriker AC, Xie Y, Chakraborty R, et al. TET2 protects against vascular smooth muscle cell apoptosis and intimal thickening in transplant vasculopathy. Circulation. 2021;144:455\u201370.","journal-title":"Circulation"},{"key":"6262_CR15","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1038\/nature23548","volume":"549","author":"PG Miller","year":"2017","unstructured":"Miller PG, Ebert BL. Leukaemia: vitamin C regulates stem cells and cancer. Nature. 2017;549:462\u20134.","journal-title":"Nature"},{"key":"6262_CR16","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/nature12362","volume":"500","author":"K Blaschke","year":"2013","unstructured":"Blaschke K, Ebata KT, Karimi MM, et al. Vitamin C induces Tet-dependent DNA demethylation and a blastocyst-like state in ES cells. Nature. 2013;500:222\u20136.","journal-title":"Nature"},{"key":"6262_CR17","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.trac.2018.10.017","volume":"109","author":"H Cheng","year":"2018","unstructured":"Cheng H, Li L, Zhang M, et al. Recent advances on in vivo analysis of ascorbic acid in brain functions. Trac-Trend Anal Chem. 2018;109:247\u201359.","journal-title":"Trac-Trend Anal Chem"},{"key":"6262_CR18","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1248\/bpb.28.1943","volume":"28","author":"F Yamamoto","year":"2005","unstructured":"Yamamoto F, Kaneshiro T, Kato H, et al. Decreased tissue accumulation of 6-deoxy-6-[18F]fluoro-L-ascorbic acid in glutathione-deficient rats induced by administration of diethyl maleate. Biol Pharm Bull. 2005;28:1943\u20137.","journal-title":"Biol Pharm Bull"},{"key":"6262_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2021.101055","volume":"14","author":"P He","year":"2021","unstructured":"He P, Zhang B, Zou Y, et al. Ascorbic acid analogue 6-Deoxy-6-[18F] fluoro-L-ascorbic acid as a tracer for identifying human colorectal cancer with SVCT2 overexpression. Transl Oncol. 2021;14: 101055.","journal-title":"Transl Oncol"},{"key":"6262_CR20","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/0883-2889(92)90032-A","volume":"43","author":"F Yamamoto","year":"1992","unstructured":"Yamamoto F, Sasaki S, Maeda M. Positron labeled antioxidants: synthesis and tissue biodistribution of 6-deoxy-6-[18F]fluoro-L-ascorbic acid. Int J Rad Appl Instrum A. 1992;43:633\u20139.","journal-title":"Int J Rad Appl Instrum A"},{"key":"6262_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.570939","volume":"11","author":"Z Li","year":"2020","unstructured":"Li Z, He P, Luo G, et al. Increased tumoral microenvironmental ph improves cytotoxic effect of pharmacologic ascorbic acid in castration-resistant prostate cancer cells. Front Pharmacol. 2020;11: 570939.","journal-title":"Front Pharmacol"},{"key":"6262_CR22","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1007\/s12149-015-1012-4","volume":"29","author":"C Yi","year":"2015","unstructured":"Yi C, Yu D, Shi X, He Q, Zhang X, Zhang X. Biodistribution and estimation of radiation-absorbed doses in humans for 13N-ammonia PET. Ann Nucl Med. 2015;29:810\u20135.","journal-title":"Ann Nucl Med"},{"key":"6262_CR23","doi-asserted-by":"crossref","unstructured":"Hindorf C, Glatting G, Chiesa C, Lind\u00e9n O, Flux G; EANM Dosimetry Committee. EANM Dosimetry Committee guidelines for bone marrow and whole-body dosimetry. Eur J Nucl Med Mol Imaging. 2010;37:1238\u20131250.","DOI":"10.1007\/s00259-010-1422-4"},{"key":"6262_CR24","doi-asserted-by":"publisher","first-page":"320","DOI":"10.2967\/jnumed.122.264349","volume":"64","author":"R Laforest","year":"2023","unstructured":"Laforest R, Ghai A, Fraum TJ, et al. First-in-human evaluation of safety and dosimetry of 64Cu-LLP2A for PET imaging. J Nucl Med. 2023;64:320\u20138.","journal-title":"J Nucl Med"},{"key":"6262_CR25","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1097\/RLU.0b013e318266cd1b","volume":"37","author":"T Huang","year":"2012","unstructured":"Huang T, Wang H, Tang G, et al. Human radiation dose estimation of (11)C-CFT using whole-body PET. Clin Nucl Med. 2012;37:1159\u201362.","journal-title":"Clin Nucl Med"},{"key":"6262_CR26","first-page":"538","volume":"37","author":"MG Stabin","year":"1996","unstructured":"Stabin MG. MIRDOSE: personal computer software for internal dose assessment in nuclear medicine. J Nucl Med. 1996;37:538\u201346.","journal-title":"J Nucl Med"},{"key":"6262_CR27","doi-asserted-by":"crossref","unstructured":"Cristy M, Eckerman KF.\u00a0Specific absorbed fractions of energy at various ages from internal photon sources: VII\u2014adult male.\u00a0Oak Ridge National Laboratory; 1987.\u00a0ORNL.\/TM-8381\/V1.","DOI":"10.2172\/6233735"},{"key":"6262_CR28","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1118\/1.594586","volume":"6","author":"JL Coffey","year":"1979","unstructured":"Coffey JL, Watson EE. Calculating dose from remaining body activity: a comparison of two methods. Med Phys. 1979;6:307\u20138.","journal-title":"Med Phys"},{"key":"6262_CR29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0146-6453(91)90065-O","volume":"21","author":"ICRP","year":"1991","unstructured":"ICRP. 1990 recommendations of the International Commission on Radiological Protection: ICRP Publication 60. Ann ICRP. 1991;21:1\u2013201.","journal-title":"Ann ICRP."},{"key":"6262_CR30","doi-asserted-by":"publisher","first-page":"615","DOI":"10.3390\/nu13020615","volume":"13","author":"M Dosed\u011bl","year":"2021","unstructured":"Dosed\u011bl M, Jirkovsk\u00fd E, Mac\u00e1kov\u00e1 K, et al. Vitamin C-sources, physiological role, kinetics, deficiency, use, toxicity, and determination. Nutrients. 2021;13:615.","journal-title":"Nutrients"},{"key":"6262_CR31","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.3390\/nu11102412","volume":"11","author":"J Lykkesfeldt","year":"2019","unstructured":"Lykkesfeldt J, Tveden-Nyborg P. The pharmacokinetics of vitamin C. Nutrients. 2019;11:2412.","journal-title":"Nutrients"},{"key":"6262_CR32","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.mam.2012.12.002","volume":"34","author":"M B\u00fcrzle","year":"2013","unstructured":"B\u00fcrzle M, Suzuki Y, Ackermann D, et al. The sodium-dependent ascorbic acid transporter family SLC23. Mol Aspects Med. 2013;34:436\u201354.","journal-title":"Mol Aspects Med"},{"key":"6262_CR33","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/19986","volume":"399","author":"H Tsukaguchi","year":"1999","unstructured":"Tsukaguchi H, Tokui T, Mackenzie B, et al. A family of mammalian Na+-dependent L-ascorbic acid transporters. Nature. 1999;399:70\u20135.","journal-title":"Nature"},{"key":"6262_CR34","doi-asserted-by":"publisher","first-page":"3869","DOI":"10.3390\/nu12123869","volume":"12","author":"K Linowiecka","year":"2020","unstructured":"Linowiecka K, Foksinski M, Bro\u017cyna AA. Vitamin C transporters and their implications in carcinogenesis. Nutrients. 2020;12:3869.","journal-title":"Nutrients"},{"key":"6262_CR35","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1002\/jnr.20326","volume":"79","author":"A Astuya","year":"2005","unstructured":"Astuya A, Caprile T, Castro M, et al. Vitamin C uptake and recycling among normal and tumor cells from the central nervous system. J Neurosci Res. 2005;79:146\u201356.","journal-title":"J Neurosci Res"},{"key":"6262_CR36","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/978-94-007-2199-9_6","volume":"56","author":"JM May","year":"2012","unstructured":"May JM. Vitamin C transport and its role in the central nervous system. Subcell Biochem. 2012;56:85\u2013103.","journal-title":"Subcell Biochem"},{"key":"6262_CR37","unstructured":"Hays MT, Watson EE, Thomas SR, Stabin M. MIRD dose estimate report no. 19: radiation absorbed dose estimates from (18)F-FDG. J Nucl Med. 2002;43:210\u2013214."},{"key":"6262_CR38","doi-asserted-by":"crossref","unstructured":"Kim J, Yamamoto F, Kuwabara Y, et al. 6-[18F]fluoro-dehydroascorbic acid. Synthesis and tissue distribution in mice. Radioisotopes. 2009;58:47\u201355.","DOI":"10.3769\/radioisotopes.58.47"},{"key":"6262_CR39","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1126\/science.aaa5004","volume":"350","author":"J Yun","year":"2015","unstructured":"Yun J, Mullarky E, Lu C, et al. Vitamin C selectively kills KRAS and BRAF mutant colorectal cancer cells by targeting GAPDH. Science. 2015;350:1391\u20136.","journal-title":"Science"},{"key":"6262_CR40","first-page":"1207","volume":"24","author":"K Harding","year":"1997","unstructured":"Harding K, Thomson WH. Radiological protection and safety in medicine - ICRP 73. Eur J Nucl Med. 1997;24:1207\u20139.","journal-title":"Eur J Nucl Med"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-023-06262-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00259-023-06262-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-023-06262-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,29]],"date-time":"2023-07-29T02:05:28Z","timestamp":1690596328000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00259-023-06262-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,16]]},"references-count":40,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["6262"],"URL":"https:\/\/doi.org\/10.1007\/s00259-023-06262-9","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,16]]},"assertion":[{"value":"25 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The current study was approved by the Institutional Ethics Committee of the First Affiliated Hospital of Sun Yat-Sen University (The ethical approval number is [2021]751-1).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors affirm that all individual participants provided informed consent for anonymised evaluation and publication of their data.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}